Skip to main content
. 2021 May 24;321(1):E90–E104. doi: 10.1152/ajpendo.00651.2020

Table 1.

Whole body measurements before and after 24 h treatment with formoterol (Form) or saline

Pretreatment Posttreatment
Body weight, g
 Form 27.5 ± 0.6 25.3 ± 0.6***
 Saline 28.1 ± 0.5 27.9 ± 0.4
Food consumption, g/24 h
 Form 4.1 ± 0.3 1.3 ± 0.1***
 Saline 3.9 ± 0.2 4.2 ± 0.8
Fat, %
 Form 5.5 ± 0.7 3.9 ± 0.8***
 Saline 7.8 ± 0.7 8.6 ± 0.9*
Lean, %
 Form 94.1 ± 0.7 95.5 ± 0.8***
 Saline 92.0 ± 0.7 91.0 ± 0.8**
Liver weight, g
 Form - 1.34 ± 0.06
 Saline - 1.38 ± 0.05

Intraperitoneal injections of mice with Form (20 µg/g) or saline vehicle over 24 h, measurement of food consumption, and assessments of body fat and lean mass (%) by quantitative magnetic resonance imaging were carried out as described in materials and methods. Data are presented as means ± SE; n = 7–8 mice/group; *P < 0.05 vs. Pretreatment; **P < 0.01; ***P < 0.001.